Phase I clinical trial of intravenous recombinant human lymphotoxin-alpha derivative

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 25, Issue 4, 2006, Pages 501-504

  Wang, Feng Hua ^a   Li, Yu Hong ^a   Li, S ^a   Jiang, Wen Qi ^a   Guan, Zhong Zhen ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILL; CLINICAL TRIAL; DOSE RESPONSE; DYSPNEA; FEMALE; FEVER; HUMAN; KIDNEY TUMOR; MALE; MAXIMUM TOLERATED DOSE; MELANOMA; MIDDLE AGED; NASOPHARYNX TUMOR; PHASE 1 CLINICAL TRIAL;

ADULT; AGED; CHILLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPNEA; FEMALE; FEVER; HUMANS; KIDNEY NEOPLASMS; LYMPHOTOXIN-ALPHA; MALE; MAXIMUM TOLERATED DOSE; MELANOMA; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 42549096481     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)